Previous Next


1433


REFERENCES

1. Chardick W, Gage A, Greatbatch W: A transistorized, self contained, implantable pacemaker for the long-term correction of complete heart block. Surgery 48:643–654, 1960.

2. Rasmussen MJ, Friedman PA, Hammill SC, Rea RF: Unintentional deactivation of implantable cardioverter-defibrillators in health care settings. Mayo Clin Proc 77:855–859, 2002.

3. Eagle KA, Berger PB, Caulkins H, et al: ACC/AHA guideline update for perioperative cardiovascular evaluation for non-cardiac surgery. Published January, 2002. Available at http://www.acc.org/clinical/guidelines/perio/update/pdf/perio_update.pdf./Accessed April 25, 2004.

4. Pinski SL, Trohman RG: Interference in implanted cardiac devices. Part I. Pacing Clin Electrophysiol 25:1367–1381, 2002.

5. Pinski SL, Trohman RG: Interference in implanted cardiac devices. Part II. Pacing Clin Electrophysiol 25:1496–1509, 2002.

6. Kazatsker M, Kusniek J, Hasdai D, et al: Two pacemakers in one patient: A stimulating case. J Cardiovasc Electrophysiol 13:522, 2002.

7. Lamas GA, Rebecca GS, Braunwald NS, Antman EM: Pacemaker malfunction after nitrous oxide anesthesia. Am J Cardiol 56:995, 1985.

8. Bernstein AD, Daubert JC, Fletcher RD, et al: The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol 25:260–264, 2002.

9. Forand JM, Schweiss JF: Pacemaker syndrome during anesthesia. Anesthesiology 60:588–590, 1984.

10. Ducey J, Fincher D, Baysinger C: Therapeutic suppression of a permanent ventricular pacemaker using a peripheral nerve stimulator. Anesthesiology 75:533–536, 1991.

11. Delfaut P, Saksena S: Electrophysiologic assessment in selecting patients for multisite atrial pacing. J Interv Card Electrophysiol 4(Suppl 1):81–85, 2000.

12. Peters RW, Gold MR: Pacing for patients with congestive heart failure and dilated cardiomyopathy. Cardiol Clin 18:55–66, 2000.

13. Abraham WT, Fisher WG, Smith AL, et al: Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853, 2002.

14. Hare JM: Cardiac resynchronization therapy for heart failure. N Engl J Med 346:1902–1905, 2002.

15. Atlee J, Bernstein A: Cardiac rhythm management devices. Part I. Anesthesiology 95:1265–1280, 2001.

16. Hayes DL: Evolving indications for permanent pacing. Am J Cardiol 83:161D–165D, 1999.

17. Bevilacqua L, Hordof A: Cardiac pacing in children. Curr Opin Cardiol 13:48–55, 1998.

18. Auricchio A, Stellbrink C, Sack S, et al: The pacing therapies for congestive heart failure (PATH-CHF) study: Rationale, design, and endpoints of a prospective randomized multi-center study. Am J Cardiol 83:130D–135D, 1999.

19. Garcia-Moran E, Mont L, Brugada J: Inappropriate tachycardia detection by a biventricular implantable cardioverter defibrillator. Pacing Clin Electrophysiol 25:123–124, 2002.

20. Schreieck J, Zrenner B, Kolb C, et al: Inappropriate shock delivery due to ventricular double detection with a biventricular pacing implantable cardioverter defibrillator. Pacing Clin Electrophysiol 24:1154–1157, 2001.

21. Gras D, Mabo P, Tang T, et al: Multisite pacing as a supplemental treatment of congestive heart failure: Preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol 21:2249–2255, 1998.

22. Medina-Ravell VA, Lankipalli RS, Yan GX, et al: Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: Does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation 107:740–746, 2003.

23. Rozner MA, Gursoy S, Monir G: Perioperative care of the patient with a pacemaker. In Stone DJ, Bogdanoff DL, Leisure GS, Spiekermann BF, Mathis DD (eds): Perioperative Care: Anesthesia, Surgery and Medicine. Philadelphia, Mosby, 1997, pp 53–67.

24. Purday JP, Towey RM: Apparent pacemaker failure caused by activation of ventricular threshold test by a magnetic instrument mat during general anaesthesia. Br J Anaesth 69:645–646, 1992.

25. Bourke ME: The patient with a pacemaker or related device. Can J Anaesth 43:24–41, 1996.

26. Shapiro WA, Roizen MF, Singleton MA, et al: Intraoperative pacemaker complications. Anesthesiology 63:319–322, 1985.

27. Valls-Bertault V, Mansourati J, Gilard M, et al: Adverse events with transvenous left ventricular pacing in patients with severe heart failure: Early experience from a single centre. Europace 3:60–63, 2001.

28. Alonso C, Leclercq C, d'Allonnes FR, et al: Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: Technical aspects. Heart 86:405–410, 2001.

29. Bernstein A, Irwin M, Parsonnet V, et al: Report of the NASPE policy conference on antibradycardia pacemaker follow-up: Effectiveness, needs and resources. Pacing Clin Electrophysiol 17:1714–1729, 1994.

30. Rozner MA, Nguyen AD, Roberson JC: Inadequate pacemaker follow-up detected at the preanesthetic visit [abstract]. Anesthesiology 96:A1071, 2002.

31. Sethi KK, Bhargava M, Pandit N, et al: Experience with recycled cardiac pacemakers. Indian Heart J 44:91–93, 1992.

32. Panja M, Sarkar CN, Kumar S, et al: Reuse of pacemaker. Indian Heart J 48:677–680, 1996.

33. Hayes JJ, Juknavorian R, Maloney JD: The role(s) of the industry employed allied professional. Pacing Clin Electrophysiol 24:398–399, 2001.

34. Kleinman B, Hamilton J, Hariman R, et al: Apparent failure of a precordial magnet and pacemaker programmer to convert a DDD pacemaker to VOO mode during the use of the electrosurgical unit. Anesthesiology 86:247–250, 1997.

35. Preisman S, Cheng DC: Life-threatening ventricular dysrhythmias with inadvertent asynchronous temporary pacing after cardiac surgery. Anesthesiology 91:880–883, 1999.

36. Andersen C, Madsen GM: Rate-responsive pacemakers and anaesthesia. A consideration of possible implications. Anaesthesia 45:472–476, 1990.

37. Levine PA: Response to "Rate-adaptive cardiac pacing: Implications of environmental noise during craniotomy" [letter]. Anesthesiology 87:1261, 1997.

38. Levine PA, Balady GJ, Lazar HL, et al: Electrocautery and pacemakers: Management of the paced patient subject to electrocautery. Ann Thorac Surg 41:313–317, 1986.

39. Rozner MA, Nguyen AD: Unexpected pacing threshold changes during non-implant surgery [abstract]. Anesthesiology 96:A1070, 2002.

40. Levine PA, Gauch PRA: Utilizacão clinica da autocaptura. Reblampa 16:31–41, 2003 (translation [Portuguese] provided by author).

41. Madsen GM, Andersen C: Pacemaker-induced tachycardia during general anaesthesia: A case report. Br J Anaesth 63:360–361, 1989.

42. von Knobelsdorff G, Goerig M, Nagele H, Scholz J: Interaction of frequency-adaptive pacemakers and anesthetic management. Discussion of current literature and two case reports. Anaesthesist 45:856–860, 1996.

43. Van Hemel NM, Hamerlijnck RP, Pronk KJ, Van der Veen EP: Upper limit ventricular stimulation in respiratory rate responsive pacing due to electrocautery. Pacing Clin Electrophysiol 12:1720–1723, 1989.

44. Wong DT, Middleton W: Electrocautery-induced tachycardia in a rate-responsive pacemaker. Anesthesiology 94:710–711, 2001.

45. Chew EW, Troughear RH, Kuchar DL, Thorburn CW: Inappropriate rate change in minute ventilation rate responsive pacemakers due to interference by cardiac monitors. Pacing Clin Electrophysiol 20:276–282, 1997.

46. Rozner MA, Nishman RJ: Pacemaker-driven tachycardia revisited. Anesth Analg 88:965, 1999.
1434


47. Wallden J, Gupta A, Carlsen HO: Supraventricular tachycardia induced by Datex patient monitoring system. Anesth Analg 86:1339, 1998.

48. Center for Devices and Radiologic Health. Interaction between minute ventilation rate-adaptive pacemakers and cardiac monitoring and diagnostic equipment. Published October 14, 1998. Available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfTopic/topicinde/topindx.cfm/Accessed September 1, 2003.

49. Southorn PA, Kamath GS, Vasdev GM, Hayes DL: Monitoring equipment induced tachycardia in patients with minute ventilation rate-responsive pacemakers. Br J Anaesth 84:508–509, 2000.

50. Rozner MA, Nishman RJ: Electrocautery-induced pacemaker tachycardia: Why does this error continue? Anesthesiology 96:773–774, 2002.

51. Samain E, Schauveliege F, Henry C, Marty J: Outcome in patients with a cardiac pacemaker undergoing noncardiac surgery [abstract]. Anesthesiology 95:A142, 2001.

52. Samain E, Marty J, Souron V, et al: Intraoperative pacemaker malfunction during a shoulder arthroscopy. Anesthesiology 93:306–307, 2000.

53. Pressly N: Review of MDR Reports reinforces concern about EMI. FDA User Facility Reporting #20. Published 1997. Available at http://www.fda.gov/cdrh/fuse20.pdf/Accessed September 1, 2003.

54. Rozner MA: [Untitled letter]. Pacing Clin Electrophysiol 26:923–925, 2003.

55. Rozner MA, Trankina MF: Intrathoracic gadgets: Update on pacemakers and implantable cardioverter defibrillators. In Schwartz AJ (ed): ASA Refresher Courses in Anesthesiology. Philadelphia, Lippincott Williams & Wilkins, 2000, pp 183–199.

56. Trankina M.F., Black S, Gibby G: Pacemakers: Perioperative evaluation, management and complications. Anesthesiology 93:A1193, 2000.

57. Gimbel JR, Johnson D, Levine PA, Wilkoff BL: Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol 19:913–919, 1996.

58. Alexopoulos GS, Frances RJ: ECT and cardiac patients with pacemakers. Am J Psychiatry 137:1111–1112, 1980.

59. O'Flaherty D, Wardill M, Adams AP: Inadvertent suppression of a fixed rate ventricular pacemaker using a peripheral nerve stimulator. Anaesthesia 48:687–689, 1993.

60. Philbin DM, Marieb MA, Aithal KH, Schoenfeld MH: Inappropriate shocks delivered by an ICD as a result of sensed potentials from a transcutaneous electronic nerve stimulation unit. Pacing Clin Electrophysiol 21:2010–2011, 1998.

61. Vlay SC: Electromagnetic interference and ICD discharge related to chiropractic treatment. Pacing Clin Electrophysiol 21:2009, 1998.

62. Finfer SR: Pacemaker failure on induction of anaesthesia. Br J Anaesth 66:509–512, 1991.

63. Bohm A, Kayser S, Pinter A, Preda I: Intermittent output failure of a VVI device due to the disintegration of the generator. Pacing Clin Electrophysiol 24:127–128, 2001.

64. Grimm W, Menz V, Hoffmann J, et al: Complications of third-generation implantable cardioverter defibrillator therapy. Pacing Clin Electrophysiol 22:206–211, 1999.

65. Roth JV, Brody JD, Denham EJ: Positioning the pacing esophageal stethoscope for transesophageal atrial pacing without P-wave recording: Implications for transesophageal ventricular pacing. Anesth Analg 83:48–54, 1996.

66. Mychaskiw G, Eichhorn JH: Interaction of an implanted pacemaker with a transesophageal atrial pacemaker: Report of a case. J Clin Anesth 11:669–671, 1999.

67. Moskowitz DM, Kahn RA, Camunas J, et al: External chest wall stimulation to suppress a permanent transvenous pacemaker in a patient during endovascular stent graft placement. Anesthesiology 89:531–533, 1998.

68. Snow N: Acute myocardial ischemia during pacemaker implantation: Implication for threshold determinations and potential complications. Pacing Clin Electrophysiol 6:35–37, 1983.

69. Moss AJ, Hall WJ, Cannom DS, et al: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335:1933–1940, 1996.

70. No authors listed: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators: N Engl J Med 337:1576–1583, 1997.

71. Buxton AE, Lee KL, Fisher JD, et al: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341:1882–1890, 1999.

72. Moss AJ, Zareba W, Hall WJ, et al: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883, 2002.

73. Bernstein AD, Camm AJ, Fisher JD, et al: North American Society of Pacing and Electrophysiology policy statement. The NASPE/BPEG defibrillator code. Pacing Clin Electrophysiol 16:1776–1780, 1993.

74. Grimm W, Flores BF, Marchlinski FE: Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 15:1667–1673, 1992.

75. Hurst TM, Krieglstein H, Tillmanns H, Waldecker B: Inappropriate management of self-terminating ventricular arrhythmias by implantable cardioverter defibrillators despite a specific reconfirmation algorithm: A report of two cases. Pacing Clin Electrophysiol 20:1328–1331, 1997.

76. Prasad K, Kishore AG, Anderson MH, et al: Inappropriate shocks in patients receiving internal cardioverter-defibrillators for malignant ventricular arrhythmias. Indian Heart J 49:403–407, 1997.

77. Schumacher B, Tebbenjohanns J, Jung W, et al: B: Radio-frequency catheter ablation of atrial flutter that elicits inappropriate implantable cardioverter defibrillator discharge. Pacing Clin Electrophysiol 20:125–127, 1997.

78. Rozner MA: The patient with an implantable cardioverter-defibrillator. Prog Anesthesiol 13:43–52, 1999.

79. Swerdlow CD: Supraventricular tachycardia-ventricular tachycardia discrimination algorithms in implantable cardioverter defibrillators: State-of-the-art review. J Cardiovasc Electrophysiol 12:606–612, 2001.

80. Wilkoff BL, Cook JR, Epstein AE, et al: Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 288:3115–3123, 2002.

81. Sandner SE, Wieselthaler G, Zuckermann A, et al: Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation 104(Suppl I):I171–I176, 2001.

82. Khan IA: Long QT syndrome: Diagnosis and management. Am Heart J 143:7–14, 2002.

83. McKenna WJ, Thiene G, Nava A, et al: Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 71:215–218, 1994.

84. Brugada P, Geelen P: Some electrocardiographic patterns predicting sudden cardiac death that every doctor should recognize. Acta Cardiol 52:473–484, 1997.

85. Maron BJ, Shen WK, Link MS, et al: Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342:365–373, 2000.

86. Casavant D, Haffajee C, Stevens S, Pacetti P: Aborted implantable cardioverter-defibrillator shock during facial electrosurgery. Pacing Clin Electrophysiol 21:1325–1326, 1998.

87. Gill RM, Sweeney RJ, Reid PR: The defibrillation threshold: A comparison of anesthetics and measurement methods. Pacing Clin Electrophysiol 16:708–714, 1993.

88. Weinbroum AA, Glick A, Copperman Y, et al: Halothane, isoflurane, and fentanyl increase the minimally effective defibrillation threshold of an implantable cardioverter defibrillator: First report in humans. Anesth Analg 95:1147–1153, 2002.
1435


89. Carlson MD, Ip J, Messenger J, et al: A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 42:627–633, 2003.

90. Schwartzenburg CF, Wass CT, Strickland RA, Hayes DL: Rate-adaptive cardiac pacing: Implications of environmental noise during craniotomy. Anesthesiology 87:1252–1254, 1997.

91. Aldrete JA, Brown C, Daily J, Buerke V: Pacemaker malfunction due to microcurrent injection from a bioimpedance noninvasive cardiac output monitor. J Clin Monit 11:131–133, 1995.

92. Martin ET, Coman JA, Shellock FG, et al: Magnetic resonance imaging and cardiac pacemaker safety at 105 Tesla. J Am Coll Cardiol 43:1315–1324, 2004.

Previous Next